Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Garudafood Putra Putri Jaya Tbk. (GOOD) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Garudafood Putra Putri Jaya Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Garudafood Putra Putri Jaya Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Garudafood Putra Putri Jaya Tbk. trades at Rp302 (market cap 11.14T, 95.1K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 51K 24h volume). The key difference: Garudafood Putra Putri Jaya Tbk. is far larger — about 66.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Garudafood Putra Putri Jaya Tbk. is more actively traded (95.1K versus 51K). Which is the better fit depends on your goals.

GOODOBAT
Market Cap
11.14T167.37B
Volume
95.1K51K
Lot
951510
Turnover
28.53M12.55M
Average Price
300.03246.09
Value
28.53M12.55M
Indicative Equilibrium Price
300246
Indicative Equilibrium Volume
232.4K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

GOOD
View details
OBAT
View details

About Garudafood Putra Putri Jaya Tbk.

PT Garudafood Putra Putri Jaya (the Company) was established in Indonesia based on Notarial Deed No. 21 of Dra. Selawati Halim, S.H., dated August 24, 1994 under the name of PT Garuda Putra Putri Jaya. Based on Notarial Deed No. 12 of Popie Savitri Martosuhardjo Pharmanto, S.H., dated November 7, 2000, the Company merged with PT Tudung Putra Jaya and PT Garudafood Jaya and subsequentlychanged its name from PT Garuda Putra Putri Jaya to PT Garudafood Putra Putri Jaya based on Notarial Deed No. 44 of Popie Savitri Martosuhardjo Pharmanto, S.H., dated August 28, 2001

Read more on GOOD

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT